TribLIVE

| Business


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Mylan adds generic Detrol, HIV/AIDS drugs

On the Grid

From the shale fields to the cooling towers, Trib Total Media covers the energy industry in Western Pennsylvania and beyond. For the latest news and views on gas, coal, electricity and more, check out On the Grid today.

MYL $27.29 +$0.10

at close on THURSDAY

Daily Photo Galleries

Thursday, Nov. 29, 2012, 12:40 p.m.
 

Mylan Inc. said on Thursday that it had introduced a generic incontinence drug to the U.S. market and was selected by the South African government as a supplier of antiretroviral drugs.

Cecil-based Mylan has started selling Tolterodine Tartrate tablets, the generic version of Detrol, made by Pfizer Inc. Tolterodine Tartrate had U.S. sales of $61.5 million for the 12 months ended Sept. 30.

The company said the South African National Department of Health selected Mylan's Indian subsidiary to supply it with 31 percent of the 30 million units of HIV/AIDS drugs it will buy in a two-year period ending Dec. 31, 2014.

Mylan's share of the contract is valued at about $127.5 million.

Add Alex Nixon to your Google+ circles.

Subscribe today! Click here for our subscription offers.

 

 

 


Show commenting policy

Most-Read Stories

  1. Steelers’ Tomlin, Pirates’ Hurdle share similar philosophy
  2. Recent early retirements in NFL could be trend — or simply a coincidence
  3. Reversing the field: Pirates continue to raid Yankees for hidden skill
  4. Body pulled from river in Charleroi
  5. NFL coaches weigh in on Polamalu’s legacy
  6. Pirates notebook: Locke the choice to be 5th starter
  7. Healing touch: Shadyside jewelry designer undertakes project to help artisans in Guatemala
  8. Connellsville shakes off layoff, routs Kiski Area, 10-4
  9. Pirates’ outfield may have few defensive peers
  10. Nominees announced for Westmoreland County Scholar-Athlete awards
  11. Music festivals say ‘no’ to fans’ selfie sticks